The mechanism of osteoclast differentiation induced by IL-1

Journal of Immunology

Volumn 183, Issue 3, 2009, Pages 1862-1870

  Kim, Jung Ha ^a   Jin, Hye Mi ^a   Kim, Kabsun ^a   Song, Insun ^a   Youn, Bang Ung ^a   Matsuo, Koichi ^b   Kim, Nacksung ^a  

^a Chonnam National University Medical School   (South Korea)

^b KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR TYPE I; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C FOS; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR NFAT; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE ACTIVATION; MACROPHAGE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; BONE MARROW CELL; CYTOLOGY; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; HUMANS; INTERLEUKIN-1; MICE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; OSTEOCLASTS; PROTO-ONCOGENE PROTEINS C-FOS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, INTERLEUKIN-1 TYPE I;

EID: 68149163293     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803007     Document Type: Article

References (43)

1. Suda, T., N. Takahashi, N. Udagawa, E. Jimi, M. T. Gillespie, and T. J. Martin. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20: 345-357. (Pubitemid 30649812)
2. Teitelbaum, S. L. 2000. Bone resorption by osteoclasts. Science 289: 1504-1508.
3. Boyle, W. J., W. S. Simonet, and D. L. Lacey. 2003. Osteoclast differentiation and activation. Nature 423: 337-342.
4. Walsh, M. C., N. Kim, Y. Kadono, J. Rho, S. Y. Lee, J. Lorenzo, and Y. Choi. 2006. Osteoimmunology: interplay between the immune system and bone metabolism. Annu. Rev. Immunol. 24: 33-63.
5. Baud'huin, M., L. Duplomb, C. Ruiz Velasco, Y. Fortun, D. Heymann, and M. Padrines. 2007. Key roles of the OPG-RANK-RANKL system in bone oncology. Expert Rev. Anticancer Ther. 7: 221-232.
6. Boyce, B. F., and L. Xing. 2008. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch. Biochem. Biophys. 473: 139-146.
7. Kearns, A. E., S. Khosla, and P. J. Kostenuik. 2008. Receptor activator of nuclear factor κB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr. Rev. 29: 155-192.
8. Kim, N., P. R. Odgren, D. K. Kim, S. C. Marks, Jr., and Y. Choi. 2000. Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene. Proc. Natl. Acad. Sci. USA 97: 10905-10910.
9. Kong, Y. Y., H. Yoshida, I. Sarosi, H. L. Tan, E. Timms, C. Capparelli, S. Morony, A. J. Oliveira-dos-Santos, G. Van, A. Itie, et al. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397: 315-323.
10. Teitelbaum, S. L., and F. P. Ross. 2003. Genetic regulation of osteoclast development and function. Nat. Rev. 4: 638-649. (Pubitemid 36917505)
11. Arch, R. H., R. W. Gedrich, and C. B. Thompson. 1998. Tumor necrosis factor receptor-associated factors (TRAFs): a family of adapter proteins that regulates life and death. Genes Dev. 12: 2821-2830.
12. Walsh, M. C., and Y. Choi. 2003. Biology of the TRANCE axis. Cytokine Growth Factor Rev. 14: 251-263.
13. Kobayashi, T., P. T. Walsh, M. C. Walsh, K. M. Speirs, E. Chiffoleau, C. G. King, W. W. Hancock, J. H. Caamano, C. A. Hunter, P. Scott, et al. 2003. TRAF6 is a critical factor for dendritic cell maturation and development. Immunity 19: 353-363.
14. Lomaga, M. A., W. C. Yeh, I. Sarosi, G. S. Duncan, C. Furlonger, A. Ho, S. Morony, C. Capparelli, G. Van, S. Kaufman, et al. 1999. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13: 1015-1024.
15. Naito, A., S. Azuma, S. Tanaka, T. Miyazaki, S. Takaki, K. Takatsu, K. Nakao, K. Nakamura, M. Katsuki, T. Yamamoto, and J. Inoue. 1999. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 4: 353-362.
16. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
17. Akatsu, T., N. Takahashi, N. Udagawa, K. Imamura, A. Yamaguchi, K. Sato, N. Nagata, and T. Suda. 1991. Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro. J. Bone Mineral Res. 6: 183-189.
18. 2 production and decreasing OPG production by osteoblasts. Life Sci. 77: 615-626.
19. Kim, N., M. Takami, J. Rho, R. Josien, and Y. Choi. 2002. A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J. Exp. Med. 195: 201-209.
20. Kim, K., J. H. Kim, J. Lee, H. M. Jin, S. H. Lee, D. E. Fisher, H. Kook, K. K. Kim, Y. Choi, and N. Kim. 2005. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J. Biol. Chem. 280: 35209-35216.
21. Kim, N., Y. Kadono, M. Takami, J. Lee, S. H. Lee, F. Okada, J. H. Kim, T. Kobayashi, P. R. Odgren, H. Nakano, et al. 2005. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J. Exp. Med. 202: 589-595.
22. So, H., J. Rho, D. Jeong, R. Park, D. E. Fisher, M. C. Ostrowski, Y. Choi, and N. Kim. 2003. Microphthalmia transcription factor and PU. 1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression. J. Biol. Chem. 278: 24209-24216.
23. Matsuo, K., D. L. Galson, C. Zhao, L. Peng, C. Laplace, K. Z. Wang, M. A. Bachler, H. Amano, H. Aburatani, H. Ishikawa, and E. F. Wagner. 2004. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J. Biol. Chem. 279: 26475-26480.
24. Kim, K., J. Lee, J. H. Kim, H. M. Jin, B. Zhou, S. Y. Lee, and N. Kim. 2007. Protein inhibitor of activated STAT 3 modulates osteoclastogenesis by downregulation of NFATc1 and osteoclast-associated receptor. J. Immunol. 178: 5588-5594. (Pubitemid 46674354)
25. Lee, J., K. Kim, J. H. Kim, H. M. Jin, H. K. Choi, S. H. Lee, H. Kook, K. K. Kim, Y. Yokota, S. Y. Lee, et al. 2006. Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Blood 107: 2686-2693.
26. Kim, K., J. H. Kim, J. Lee, H. M. Jin, H. Kook, K. K. Kim, S. Y. Lee, and N. Kim. 2007. MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood 109: 3253-3259.
27. Kim, K., S. H. Lee, J. Ha Kim, Y. Choi, and N. Kim. 2008. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol. Endocrinol. 22: 176-185.
28. Jimi, E., I. Nakamura, T. Ikebe, S. Akiyama, N. Takahashi, and T. Suda. 1998. Activation of NF-κB is involved in the survival of osteoclasts promoted by interleukin-1. J. Biol. Chem. 273: 8799-8805.
29. Kwan Tat, S., M. Padrines, S. Theoleyre, D. Heymann, and Y. Fortun. 2004. IL-6, RANKL, TNF-α/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 15: 49-60.
30. Yao, Z., L. Xing, C. Qin, E. M. Schwarz, and B. F. Boyce. 2008. Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism. J. Biol. Chem. 283: 9917-9924.
31. Luchin, A., S. Suchting, T. Merson, T. J. Rosol, D. A. Hume, A. I. Cassady, and M. C. Ostrowski. 2001. Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation. J. Biol. Chem. 276: 36703-36710.
32. Partington, G. A., K. Fuller, T. J. Chambers, and M. Pondel. 2004. Mitf-PU.1 interactions with the tartrate-resistant acid phosphatase gene promoter during osteoclast differentiation. Bone 34: 237-245.
33. O'Neill, L. 2000. The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defense. Biochem. Soc. Trans. 28: 557-563.
34. Findlay, D. M., and D. R. Haynes. 2005. Mechanisms of bone loss in rheumatoid arthritis. Modern Rheum. 15: 232-240.
35. Nakamura, I., and E. Jimi. 2006. Regulation of osteoclast differentiation and function by interleukin-1. Vitamins Hormones 74: 357-370.
36. Kobayashi, K., N. Takahashi, E. Jimi, N. Udagawa, M. Takami, S. Kotake, N. Nakagawa, M. Kinosaki, K. Yamaguchi, N. Shima, et al. 2000. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191: 275-286.
37. Kitazawa, R., R. B. Kimble, J. L. Vannice, V. T. Kung, and R. Pacifici. 1994. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J. Clin. Invest. 94: 2397-2406. (Pubitemid 24379614)
38. Lorenzo, J. A., A. Naprta, Y. Rao, C. Alander, M. Glaccum, M. Widmer, G. Gronowicz, J. Kalinowski, and C. C. Pilbeam. 1998. Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy. Endocrinology 139: 3022-3025.
39. Bajayo, A., I. Goshen, S. Feldman, V. Csernus, K. Iverfeldt, E. Shohami, R. Yirmiya, and I. Bab. 2005. Central IL-1 receptor signaling regulates bone growth and mass. Proc. Natl. Acad. Sci. USA 102: 12956-12961.
40. Vargas, S. J., A. Naprta, M. Glaccum, S. K. Lee, J. Kalinowski, and J. A. Lorenzo. 1996. Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor. J. Bone Mineral Res. 11: 1736-1744.
41. Asagiri, M., K. Sato, T. Usami, S. Ochi, H. Nishina, H. Yoshida, I. Morita, E. F. Wagner, T. W. Mak, E. Serfling, and H. Takayanagi. 2005. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202: 1261-1269.
42. Takayanagi, H., S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, et al. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3: 889-901.
43. Sharma, S. M., A. Bronisz, R. Hu, K. Patel, K. C. Mansky, S. Sif, and M. C. Ostrowski. 2007. MITF and PU. 1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation. J. Biol. Chem. 282: 15921-15929.